STOCK TITAN

Insider sale notice for BioMarin (NASDAQ: BMRN) via Fidelity Brokerage Services

Filing Impact
(Neutral)
Filing Sentiment
(Neutral)
Form Type
144

Rhea-AI Filing Summary

BMRN Form 144 filing reporting an intended sale of Common Stock through a broker. The filing lists Fidelity Brokerage Services LLC as the broker and shows 03/11/2026 as a filing date.

The filing itemizes securities tied to compensation and ESPP with quantities and dates: 1,857 shares (restricted stock vesting on 05/04/2023), 133 shares (ESPP purchase on 10/31/2023), and 14,496 shares (restricted stock vesting on 03/15/2024).

Positive

  • None.

Negative

  • None.

Insights

Routine Rule 144 notice for proposed resale of restricted and ESPP shares.

The filing names Fidelity Brokerage Services LLC as the broker and records a filing date of 03/11/2026. It itemizes shares acquired via restricted stock vesting and an ESPP purchase with explicit dates and quantities.

These disclosures are procedural: they notify the market of an intended sale under resale conditions. Timing, sale method, and proceeds are not specified in the excerpt; subsequent transaction details will appear in trade reports or Form 4/Form 144 amendments if sales occur.

144: Filer Information

144: Issuer Information

144: Securities Information



Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold


* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.



Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

144: Remarks and Signature

FAQ

What does BMRN's Form 144 disclose?

It discloses a notice of proposed sale of common stock through Fidelity Brokerage Services LLC on 03/11/2026. The filing lists specific lots: 1,857, 133, and 14,496 shares tied to vesting and ESPP dates.

Does the filing state how the shares will be sold?

No. The excerpt names the broker but does not specify sale methods or timing. Details on block trades, market sales, or proceeds are not included in the provided excerpt.

Are the listed shares newly issued or from compensation plans?

The filing shows shares acquired via compensation events: restricted stock vesting on 05/04/2023 and 03/15/2024, and an ESPP purchase on 10/31/2023. Quantities are explicitly listed in the excerpt.

Will this Form 144 change BMRN's outstanding share count?

No such change is stated. The filing is a resale notice; it does not amend authorized or outstanding share counts. Any effect on outstanding shares would result from actual trades, which are not shown here.

Where can investors find confirmation if the shares are sold?

Trade confirmations or subsequent SEC filings (Form 4 or amended Form 144) will show actual sales. This excerpt does not include sale completion details or proceeds.
Biomarin Pharmaceutical Inc

NASDAQ:BMRN

View BMRN Stock Overview

BMRN Rankings

BMRN Latest News

BMRN Latest SEC Filings

BMRN Stock Data

11.36B
190.74M
Biotechnology
Pharmaceutical Preparations
Link
United States
NOVATO